Recombinant protein expression technology serves a wide range of downstream scenarios including scientific research and industrial manufacturing. Different applications require tailored protein expression systems. Major considerations in system selection cover protein functionality, solubility, production timeline and yield.

Leveraging proven experience in developing over 150 high-end proteins, Yinjia Bio has built a comprehensive protein development platform empowered by cutting-edge technologies such as computer simulation and AI-assisted design. We deliver high-end protein raw materials with superior quality, distinctive technical barriers, high stability and cost competitiveness, benchmarking global leading suppliers for clinical diagnostics, personalized medication guidance, new drug research and other fields.

Yinjia Bio offers custom protein development services based on multiple mature expression platforms, including prokaryotic, yeast, baculovirus-insect cell, and mammalian cell systems.